Check-Cap updates offering for reverse share split
Check-Cap Ltd. filed a prospectus supplement updating an existing F-1 prospectus for an offering of up to 266,551 Ordinary Shares following a 1-for-7 reverse share split of its Ordinary Shares.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Check-Cap Ltd. filed a prospectus supplement updating an existing F-1 prospectus for an offering of up to 266,551 Ordinary Shares following a 1-for-7 reverse share split of its Ordinary Shares. The Board approved the split on July 31, 2026, with shareholder approval obtained on November 14, 2025.
The reverse split became effective on August 13, 2026, when every seven issued and outstanding Ordinary Shares were combined into one, with fractional shares rounded up. As a result, issued and outstanding Ordinary Shares were reduced from approximately 9,463,062 to approximately 1,351,866, without changing par value or authorized share capital, and without altering shareholder percentage ownership apart from rounding effects.
The Ordinary Shares trade on the Nasdaq Capital Market under the symbol MBAI, and the last reported sale price on August 12, 2026 was $1.27 per share. The reverse split did not modify the Purchase Agreement with ARC Group International Ltd.
Key Figures
Key Terms
par value financial
Registration Statement on Form F-1 regulatory
prospectus supplement regulatory
Nasdaq Capital Market market
Offering Details
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does Check-Cap Ltd. (MBAI) disclose in this 424B3 supplement?
What remained unchanged at Check-Cap Ltd. (MBAI) after the reverse split?
AI-generated analysis. How Rhea-AI works. Not financial advice.
